This study examined the frequency of Vα24+/Vβ11+ natural-killer T (NKT) cells from peripheral blood and bronchoalveolar lavage fluid in pulmonary tuberculosis (TB) patients with or without diabetes mellitus (DM). The clinical grade of TB was significantly higher among diabetic patients. NKT cells from both peripheral blood and bronchoalveolar lavage were significantly increased in diabetic TB patients compared with non-diabetic TB patients. This may be due to the generally higher bacillary burden in diabetic TB patients. NKT cells from peripheral blood mononuclear cells in TB patients with or without DM were significantly increased, compared with levels in non-TB diabetic patients and healthy controls. The measurement of NKT cells from peripheral blood has the potential to be a reliable, non-invasive, practical diagnostic marker for active TB.
SugawaraIMizunoS: Higher susceptibility of type 1 diabetic rats to Mycobacterium tuberculosis infection. Tohoku J Exp Med2008; 216: 363–370.
7.
Al-AttiyahRJMustafaAS: Mycobacterial antigen-induced T helper type 1 (Th1) and Th2 reactivity of peripheral blood mononuclear cells from diabetic and non-diabetic tuberculosis patients and Mycobacterium bovis bacilli Calmette–Guérin (BCG)-vaccinated healthy subjects. Clin Exp Immunol2009; 158: 64–73.
8.
AlisjahbanaBVan CrevelRSahiratmadjaE: Diabetes mellitus is strongly associated with tuberculosis in Indonesia. Int J Tuberc Lung Dis2006; 10: 696–700.
9.
Tuberculosis Research Committee (Ryojen): Relapse rate of tuberculosis treated with standard regimen of chemotherapy. Kekkaku2009; 84: 617–625 [in Japanese, English abstract].
10.
ZhangQXiaoHSugawaraI: Tuberculosis complicated by diabetes mellitus at Shanghai Pulmonary Hospital, China. Jpn J Infect Dis2009; 62: 390–391.
11.
ChoiH-JXuHGengY: Bacterial infection alters the kinetics and function of iNKT cell responses. J Leukoc Biol2008; 84: 1462–1471.
12.
FussIHellerFBoirivantM: Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis. J Clin Invest2004; 113: 1490–1497.
13.
MattnerJDebordKIsmailN: Exogenous and endogenous glycolipid antigen activated NKT cells during microbial infections. Nature2005; 434: 525–529.
14.
YangYUenoABaoM: Control of NKT cell differentiation by tissue-specific microenvironments. J Immunol2003; 171: 5913–5920.
15.
LeePTPutnamABenlaghaK: Testing the NKT cell hypothesis of human IDDM pathogenesis. J Clin Invest2002; 110: 793–800.
16.
Snyder-CappioneJENixonDFLooCP: Individuals with pulmonary tuberculosis have lower levels of circulating CD1d-restricted NKT cells. J Infect Dis2007; 195: 1361–1364.
17.
SugawaraIYamadaHMizunoS: Mycobacterial infection in natural killer T cell knockout mice. Tuberculosis (Edinb)2002; 82: 97–104.
18.
World Health Organization (WHO): Definition, diagnosis and classification of diabetes mellitus and its complications. In: WHO Report No. WHO/NCD/NCS/99.2. Geneva: World Health Organization, 2002; pp 48–49.
19.
TsaoTCChenCHHongJH: Shifts of T4/T8 T lymphocytes from BAL fluid and peripheral blood by clinical grade in patients with pulmonary tuberculosis. Chest2002; 122: 1285–1291.
20.
KulpraneetMSukwitSSumransurpK: Cytokine production in NK and NKT cells from Mycobacterium tuberculosis infected patients. Southeast Asian J Trop Med Public Health2007; 38: 370–375.
21.
SutherlandJSJeffriesDJDonkorS: High granulocyte/lymphocyte ratio and paucity of NKT cells defines TB disease in a TB-endemic setting. Tuberculosis2009; 89: 398–404.
22.
Sada-OvalleIChibaAGonzalesA: Innate invariant NKT cells recognize Mycobacterium tuberculosis-infected macro-phages, produce interferon-γ, and kill intracellular bacteria. PLoS Pathog2007; 4: e1000239.
23.
TupinEKinjoYKronenbergM: The unique role of natural killer T cells in the response to microorganisms. Nat Rev Microbiol2007; 5: 405–417.
24.
ApostolouITakahamaYBelmantC: Murine natural killer T (NKT) cells contribute to the granulomatous reaction caused by mycobacterial cell walls. Proc Natl Acad Sci USA1999; 96: 5141–5148.
25.
GansertJLKiesslerVEngeleM: Human NKT cells express granulysin and exhibit antimycobacterial activity. J Immunol2003; 170: 3154–3161.
26.
Al MajidFMAbbaAA: Immunophenotypic characterisation of peripheral T lymphocytes in pulmonary tuberculosis. J Postgrad Med2008; 54: 7–11.
27.
SridharCBKiniUSubhashK: Comparative cytological study of lymph node tuberculosis in HIV-infected individuals and in patients with diabetes in a developing country. Diagn Cytopathol2002; 26: 75–80.
28.
FlynnJLChanJ: Tuberculosis latency and reactivation. Infect Immun2001; 69: 4195–4201.
29.
KadowakiNAntonenkoSHoS: Distinct cytokine profiles of neonatal natural killer T cells after expansion with subsets of dendritic cells. J Exp Med2001; 193: 1221–1226.
ZahranWAGhonaimMMKouraBA: Human natural killer T cells, NK and T cells in pulmonary tuberculosis: Potential indicators for disease activity and prognosis. Egypt J Immunol2006; 13: 67–78.
32.
VenkataswamyMMBaenaAGoldbergMF: Incorporation of NKT cell-activating glycolipids enhances immunogenicity and vaccine efficacy of Mycobacterium bovis bacillus Calmette–Guérin. J Immunol2009; 183: 1644–1656.
33.
CohenNRGargSBrennerMB: Antigen presentation by CD1 lipids, T cells, and NKT cells in microbial immunity. Adv Immunol2009; 102: 1–94.
34.
ChackerianAAltJPereraV: Activation of NKT cells protects mice from tuberculosis. Infect Immun2002; 70: 6302–6309.
35.
MaâlejSBelhaouiNBourguibaM: Pulmonary tuberculosis and diabetes. A retrospective study of 60 patients in Tunisia. Presse Med2009; 38: 20–24 [in French, English abstract].
36.
WangCSYangCJChenHC: Impact of type 2 diabetes on manifestations and treatment outcome of pulmonary tuberculosis. Epidemiol Infect2009; 137: 203–210.
37.
GriseriTBeaudoinLNovakJ: Invariant NKT cells exacerbate type 1 diabetes induced by CD8 T cells. J Immunol2005; 175: 2091–2101.
38.
RestrepoBIFisher-HochSPPinoPA: Tuberculosis in poorly controlled type 2 diabetes: Altered cytokine expression in peripheral white blood cells. Clin Infect Dis2008; 47: 634–641.
